Page 289 - Programme book for The International Liver Congress 2015, EASL ILC 2015

YI P0970 FAT-LADDEN MACROPHAGES MODULATE LOBULAR ePOSTERS
YI P0971 INFLAMMATION IN NONALCOHOLIC STEATOHEPATITIS
(NASH)
YI P0972 Salvatore Sutti*, Stefania Bruzzì, Aastha Jindal, Irene Locatelli,
YI P0973 Marco Vacchiano, Cristina Bozzola, Emanuele Albano, Italy

YI P0974 A DIET-INDUCED MOUSE MODEL OF NONALCOHOLIC
FATTY LIVER DISEASE WITH PROGRESSION TO ADVANCED
FIBROSIS AND HEPATOCELLULAR CARCINOMA WITH
A GENE EXPRESSION SIGNATURE MIMICKING HUMAN
DISEASE
Amon Asgharpour*, Pierre Bedossa,Yujin Hoshida, Sophie Cazanave,
Robert Vincent, Tommy Pacana, Faridoddin Mirshahi,
Mulugeta Sheneshaw, Kalyani Daita, Puneet Puri, Arun Sanyal,
The United States

EXPRESSIONS OF BILE ACID TRANSPORTERS ARE
INVERSELY CORRELATED WITH NAFLD ACTIVITY SCORE
IN THE LIVER OF PATIENTS WITH NON-ALCOHOLIC FATTY
LIVER DISEASE
Kazuya Okushin*, Takeya Tsutsumi, Kenichiro Enooku, Akira Kado,
Hidetaka Fujinaga, Kyoji Moriya, Hiroshi Yotsuyanagi, Kazuhiko Koike,
Japan

QUERCETIN AMELIORATES MCD-INDUCED NON-
ALCOHOLIC FATTY LIVER DISEASE IN MICE BY
MODULATING INFLAMMATORY, OXIDATIVE/NITROSATIVE
STRESS AND LIPID METABOLISM-RELATED GENE
DEREGULATION VIA THE PI3K/AKT PATHWAY
Sandra Pisonero-Vaquero*, Ángel Martínez-Ferreras,
María Victoria García-Mediavilla, Susana Martínez-Flórez,
Anna Fernández, Marta Benet, José Luis Olcoz, Ramiro Jover,
Javier González-Gallego, Sonia Sánchez-Campos, Spain

EFFECTS OF RESVERATROL ON EXPERIMENTAL NON-
ALCOHOLIC STEATOHEPATITIS
Sara Heebøll*, Karen L. Thomsen, Andrew Clouston, Niels Jessen,
Elias I. Sundelin, Steen B. Pedersen,Yulia Radko, Lars P. Christensen,
Lionel Hebbard, Henning Grønbæk, Jacob George, Denmark

Vienna, Austria • April 22–26, 2015 289